Education
About Us
Working with TipRanks
Follow Us
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
Technical Sentiment
Overall Consensus
Strong Buy
14Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is 0.46, suggesting BridgeBio Oncology Therapeutics is a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 11.04, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.03, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 10.64, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.03, making it a Buy.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
10.72
10.96
11.27
11.51
11.82
12.06
12.37
Fibonacci
10.96
11.17
11.30
11.51
11.72
11.85
12.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
11.72Buy
11.70Buy
MA10
11.55Buy
11.45Buy
MA20
10.89Buy
11.04Buy
MA50
10.37Buy
10.64Buy
MA100
10.57Buy
10.58Buy
MA200
10.67Buy
10.59Buy
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 11.45, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.03, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 10.58, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.03, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.03 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 10.37, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.03 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 10.57, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.03 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 10.67, creating a Buy signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
61.37
Neutral
STOCH (9,6)
66.65
Neutral
STOCHRSI (14)
77.09
Neutral
MACD (12,26)
0.46
Sell
ADX (14)
35.89
Neutral
Williams %R
-11.07
Sell
CCI (14)
84.03
Neutral
ATR (14)
1.02
-
Ultimate Oscillator
56.13
Neutral
ROC
18.29
Buy
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 61.37, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 35.89, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is 84.03, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is 18.29, creating a Buy signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Strong Buy.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 61.37, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is 0.46, which suggests BBOT is a Sell.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 11.72, which suggests BBOT is a Buy.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 10.89, which suggests BBOT is a Buy.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 10.37, which suggests BBOT is a Buy.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 10.67, which suggests BBOT is a Buy.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -11.07, which suggests BBOT is a Sell.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is 84.03, which suggests BBOT is a Neutral.